Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
625.00    -27.00 (-4.14%)
Bid:
620.00
Ask:
630.00
Spread: 10.00 (1.613%)
Market Cap: £210.14m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Acquisition of Aerospace Assets

16 Nov 2012 08:57

16 November Avingtrans plc ("Avingtrans", "Group" or "the Company") Acquisition of Aerospace Assets

Avingtrans plc, which designs, manufactures and supplies critical components and associated services to the global aerospace, energy, and medical sectors, announces that it has agreed to acquire the trade and certain business assets and liabilities relating to the manufacture of aerospace components from PFW UK Limited's Farnborough site ("PFW Farnborough" and the "Acquisition") for a cash consideration of £1.85 million. The acquisition is due to be completed on 3 December 2012, following the completion of final targeted due diligence and employee consultation.

Highlights of the Acquisition:

* Strengthens the Group's Aerospace division * Cash consideration of £1.85m * Reinforces Avingtrans' position with certain existing customers as well as introducing new customers to the Group * Broadens process and design capabilities to expand aerospace market offering

Information on the assets being acquired

The principal activity of the PFW Farnborough business is the manufacture of a wide range of precision aerospace components, from pipes and ducts to airframe structures. The directors of Avingtrans (the "Board") believe that the Acquisition enhances the Group's Aerospace components and sub-assemblies offering and the Board are pleased to have taken further steps in implementing the Group's strategy, outlined recently after the disposal of the Company's Industrial Products division. PFW Farnborough has a number of customers in common with Avingtrans, as well as several customers with whom the Company has no existing commercial relationship. The Board therefore believes that the acquisition will both strengthen its current portfolio and also add valuable new sales channels.

PFW Farnborough generated revenues of £7.5 million* and a trading loss of £1.8 million* during the year ended 31 December 2011. However, the Board believes that its current run rate and the potential is materially higher. The net book value of the assets and liabilities being acquired has been valued at £2.3m million as at 30 September 2012*. PFW Farnborough employs 102 people in the UK, all of whom are expected to transfer to Avingtrans following an appropriate consultation process.

Steve McQuillan, Chief Executive of Avingtrans commented:

"The recent sale of Jena Tec provided us with a more focused business and the means to invest in our core activities, including in our thriving Aerospace division. This acquisition will further strengthen our position in the aerospace pipes market, making us a leading player in this niche in the UK. We will develop the PFW Farnborough capabilities to broaden our product offering and thus expand our aerospace supply footprint.

"With the proceeds from the Jena Tec disposal, we will continue to explore opportunities which would improve our customer reach and thereby further strengthen our position in this attractive market."

* Source: PFW Farnborough unaudited management information, prepared under generally accepted accounting principles in the UK

-ends- Avingtrans plc Tel: 01159 499 020 Steve McQuillan, Chief Executive Officer finnCap (Nominated Advisor & Broker) Tel: 020 7220 0500 Marc Young/ Henrik Persson Newgate Threadneedle(Financial PR) Tel: 020 7653 9850

Josh Royston

XLON
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.